Sunshine Biopharm…
USUSDSunshine Biopharma Inc (US:SBFM) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 1. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
Om virksomheden
- Websted
- sunshinebiopharma.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Hovedkontor
- FORT LAUDERDALE, United States
- Administrerende direktør
- Dr. Steve N. Slilaty Ph.D.
- Ansatte
- 50
- Udestående aktier
- 3.88 mio. pr. 2026-08-13
- Free float
- 3.81 mio.
- Markedsværdi
- 2.58 mio. USD
- Insidere
- 1.59%
- Institutionelle investorer
- 6.42%
- Branche (SIC)
- Pharmaceutical Preparations
Beskrivelse
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Børser og tickere
| Børs | Ticker | Valuta | Pris | Type |
|---|---|---|---|---|
| US USA Stocks | SBFM | USD | 0.7 +75.92% | almindelige aktier |
Udbytte
Ingen udbyttebetalinger fundet (tjekket 08.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.
Nyheder denne uge
Endnu ingen nyheder fra virksomhedens websted.
Største ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| NATAN DAVID (Director) | ≈2.58% | 100 000 | 2026-04-14 |
| Jane Street Group, LLC | 0.35% | 14 974 | 2026-06-30 |
| Morgan Stanley | 0.01% | 385 | 2026-06-30 |
| SBI Securities Co., Ltd. | 0% | 162 | 2026-06-30 |
| Fidelity NASDAQ Composit… | 0% | 11 | 2024-08-31 |
| National Bank of Canada/… | 0% | 5 | 2026-06-30 |
| Osaic Holdings Inc. | 0% | 2 | 2026-06-30 |
| Farther Finance Advisors… | 0% | 1 | 2026-06-30 |
| TD Waterhouse Canada Inc… | 0% | 1 | 2026-06-30 |
| Strive Financial Group ,… | 0% | 1 | 2026-06-30 |
| Caitong International As… | 0% | 1 | 2026-06-30 |
